NBSE - NeuBase Therapeutics EPS beats by $0.05 February, 11 2021 04:58 PM NeuBase Therapeutics Inc. NeuBase Therapeutics (NBSE): FQ1 GAAP EPS of -$0.18 beats by $0.05.At Dec. 31, 2020, the Company had cash and equivalents of ~$28.0M.Press Release For further details see: NeuBase Therapeutics EPS beats by $0.05